Positron Corporation (POSC)

Market Cap	82.07M +191.8%
Revenue (ttm)	486.45K -63.4%
Net Income	-4.83M
EPS	-0.16
Shares Out	32.85M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,255
Average Volume	196,503
Open	2.460
Previous Close	2.440
Day's Range	2.330 - 2.620
52-Week Range	1.220 - 2.740
Beta	0.75
RSI	64.39
Earnings Date	Mar 31, 2026

About Positron

Positron Corporation develops, manufactures, and sells cardiac positron emission tomography imaging systems in the United States. The company offers Attrius PET and NeuSight PET-CT 64-slice used in non-invasive diagnosis and evaluation of coronary artery disease and supports various molecular imaging applications, including cardiology, oncology, and neurology. It also provides clinical and technical support services, such as physician interpretation training, nurse and technologist training, billing and prior-authorization assistance, physician...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1983
• Employees: 10
• Stock Exchange: OTCMKTS
• Ticker Symbol: POSC

Financial Performance

In 2024, Positron's revenue was $587,500, a decrease of -20.03% compared to the previous year's $734,666. Losses were -$2.38 million, 45.3% more than in 2023.